Bioactivity | AK-001 is a fully human IgG1 antibody that targets Siglec-8. VRC-01 can be used for the study of chronic rhinosinusitis with nasal polyps. The isotype control for AK-001 can refer to Human IgG1 kappa, Isotype Control (HY-P99001)[1]. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Boechat JL, et al. Biologicals in severe chronic rhinosinusitis with nasal polyps: translation to clinical practice while waiting for head-to-head studies. Rhinology. 2023 Jun 1;61(3):283-286. |